Industry
Medical - Healthcare Information Services
Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Loading...
Open
0.12
Mkt cap
1.1M
Volume
1.1M
High
0.12
P/E Ratio
-0.04
52-wk high
7.39
Low
0.10
Div yield
N/A
52-wk low
0.10
Portfolio Pulse from Benzinga Insights
October 11, 2024 | 8:31 pm
Portfolio Pulse from Benzinga Newsdesk
October 01, 2024 | 8:13 pm
Portfolio Pulse from Benzinga Newsdesk
September 10, 2024 | 11:01 am
Portfolio Pulse from Benzinga Newsdesk
September 09, 2024 | 10:05 am
Portfolio Pulse from Benzinga Newsdesk
September 06, 2024 | 3:29 pm
Portfolio Pulse from Benzinga Newsdesk
August 26, 2024 | 9:50 am
Portfolio Pulse from Benzinga Newsdesk
August 21, 2024 | 12:02 pm
All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.